CN106913909A - It is a kind of to dry bioprosthesis valve and preparation method thereof - Google Patents

It is a kind of to dry bioprosthesis valve and preparation method thereof Download PDF

Info

Publication number
CN106913909A
CN106913909A CN201710108807.0A CN201710108807A CN106913909A CN 106913909 A CN106913909 A CN 106913909A CN 201710108807 A CN201710108807 A CN 201710108807A CN 106913909 A CN106913909 A CN 106913909A
Authority
CN
China
Prior art keywords
valve
preparation
bioprosthesis
drying
bioprosthesis valve
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201710108807.0A
Other languages
Chinese (zh)
Other versions
CN106913909B (en
Inventor
邝大军
余金城
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HANGZHOU QIMING MEDICAL DEVICE CO Ltd
Original Assignee
HANGZHOU QIMING MEDICAL DEVICE CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HANGZHOU QIMING MEDICAL DEVICE CO Ltd filed Critical HANGZHOU QIMING MEDICAL DEVICE CO Ltd
Priority to CN201710108807.0A priority Critical patent/CN106913909B/en
Publication of CN106913909A publication Critical patent/CN106913909A/en
Application granted granted Critical
Publication of CN106913909B publication Critical patent/CN106913909B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A61L27/3625Vascular tissue, e.g. heart valves
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A61L27/3687Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by the use of chemical agents in the treatment, e.g. specific enzymes, detergents, capping agents, crosslinkers, anticalcification agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00Materials or treatment for tissue regeneration
    • A61L2430/20Materials or treatment for tissue regeneration for reconstruction of the heart, e.g. heart valves
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00Materials or treatment for tissue regeneration
    • A61L2430/40Preparation and treatment of biological tissue for implantation, e.g. decellularisation, cross-linking

Abstract

The present invention disclose it is a kind of dry bioprosthesis valve and preparation method thereof, the preparation method includes step:By in the polymer solution of the bioprosthesis valve immersion hydroxyl after crosslinked fixation, taken out after the immersion scheduled time and dried at 5~45 DEG C, obtain drying bioprosthesis valve.Bioprosthesis valve is dried using prepared by preparation method of the present invention, with good physicochemical property and biocompatibility;Preparation method of the present invention improves the service life of valve, makes valve that flexible nature still can be kept in the state of drying, so as to reduce production, the cost of transportation of valve, simplifies the use flow of valve.

Description

It is a kind of to dry bioprosthesis valve and preparation method thereof
Technical field
The present invention relates to medical instruments field, more particularly to a kind of dry bioprosthesis valve and preparation method thereof.
Background technology
With economic development and aging population, the incidence of disease of veteran form calcific aortic disease (CAVD) is presented The trend of liter, as the angiocardiopathy for being only second to coronary heart disease and hypertension.The retrospective non-randomized studies analysis prompting of one, China The incidence of disease of the middle-older patient calcific aortic valve (AVC) of more than 50 years old is up to 49.38%.With the aging of population, calcification Property aortic stenosis (CAS) the incidence of disease increase, will turn into China's valvular heart disease the primary cause of disease.
Aorta petal plant is carried out using artificial valve change the gold mark that (AVR) is the various types of aortic valve diseases for the treatment of It is accurate.It is increasing (TAVR, or TAVI) art application trend worldwide to be inserted through conduit sustainer bioprosthetic valves.This can Can be because compared with the excessive risk of conventional surgical AVR, the technology be reduced the potentiality of the death rate and the incidence of disease.Through conduit actively Arteries and veins valve implantation is smaller as a kind of wound, and the relatively low treatment method of risk gives severe aortic stenosis in patients, particularly The patient of open chest surgery is unable to, new hope is brought.With widely using for intervention artificial heart biological cardiac valve, how it is improved Service life, the failure for reducing biovalve is the important problem that we face.
Existing biovalve is essentially all to be crosslinked using single glutaraldehyde solution, and reach makes under certain condition With the mechanical property and durability of scope, and possess good biocompatibility, then biovalve is sewed and is remembered in one kind On metallic support, then it is stored in finite concentration glutaraldehyde preservation liquid.Before Cardiac valve replacement is carried out, by valve Film is transported to hospital operating room, and valve is cleaned, and valve is delivered in heart of patient by conveyer device then. During the making of above-mentioned valve, sewing, transport and use, valve must be maintained in specifically preserving in liquid and ensure that valve is Wet state.
Biovalve after domestic and international existing crosslinking is during making, sewing, transport and use, it is necessary to be stored in spy In fixed preservation liquid and ensure that valve is wet state so that valve needs extra condition so that preparing in preparation process Process is cumbersome, valve must be separated with conveyer in transportation, and valve needs preoperative loading, and valve must be washed during loading The preservation liquid of upper residual, causes easily loss to cause calcification and inactivate and increase the risk of bacterial infection, while limit its clinic should With popularization, the cost that biovalve preserves, transports and use is increased.And biovalve is by after glutaraldehyde cross-linking, valve Can usually remain the carboxyl on the unpaired aldehyde radical from glutaraldehyde and valve proteinaceous tissue on film, aldehyde radical and carboxyl easily with Calcium binding, causes there are calcification sites in bioprosthetic valves, and this is a major reason for causing bioprosthetic valves calcification.Simultaneously because wet Film is loaded, and valve compressed dimension cannot further reduce, and reduces patient's accommodation, and limitation valve is inserted path, be increased Vascular complication.
With the gradually accumulation of TAVR clinical experiences, its complication is gradually decreased, and idicatio has gradually to younger trouble Person, in it is low danger patient extension trend.At present it is all it is commercialized through conduit aortic valve in application process, potential problems Gradually highlight, mainly include as follows:
1. valve durability is inadequate, it is impossible to meet valvular heart disease people's rejuvenation trend;
2. valve compressed dimension cannot further reduce, and reduce patient's accommodation, and limitation valve is inserted path, increased Vascular complication;
3. valve need preoperative loading, easy calcification and inactivate, the defect such as poor durability and manufacture accumulating condition harshness limits it Clinical practice is promoted;
4. the biocompatibility of existing artificial bio-prosthetic valve is still not enough;The biocompatibility of artificial bio-prosthetic valve is influence valve One major reason of film service life, eliminates the immunogenicity of valve and can strengthen host ECs and climb and cover function, reduces Perivalvular leakage Probability.
Therefore, prior art has yet to be improved and developed.
The content of the invention
In view of above-mentioned the deficiencies in the prior art, bioprosthesis valve and its system are dried it is an object of the invention to provide a kind of Preparation Method, it is intended to solve existing bioprosthesis valve durability not enough, valve compressed dimension cannot further reduce, valve is needed Preoperative loading, easy calcification and inactivate, manufacture accumulating condition is harsh and problem of poor biocompatibility.
Technical scheme is as follows:
A kind of preparation method for drying bioprosthesis valve, including step:By the bioprosthesis valve after crosslinked fixation Immerse in the polymer solution of hydroxyl, taken out after the immersion scheduled time and dried at 5~45 DEG C, obtain drying artificial bio-prosthetic valve Film.
The described preparation method for drying bioprosthesis valve, wherein, the polymer solution of the hydroxyl is poly- second two One or more mixed solution in alcohol, polyvinyl alcohol, polyether Glycols solution.
The described preparation method for drying bioprosthesis valve, wherein, the concentration of the polymer solution of the hydroxyl is 10%~50%.
The described preparation method for drying bioprosthesis valve, wherein, the scheduled time is 1~7 day.
The described preparation method for drying bioprosthesis valve, wherein, by the bioprosthesis valve leaching after crosslinked fixation When being soaked in the polymer solution for entering hydroxyl, soaking temperature is 25~45 DEG C.
The described preparation method for drying bioprosthesis valve, wherein, by the bioprosthesis valve leaching after crosslinked fixation It is 3.0~5.5 by adding hydrochloric acid control solution pH value when being soaked in the polymer solution for entering hydroxyl.
The described preparation method for drying bioprosthesis valve, wherein, bioprosthesis valve is carried out using glutaraldehyde solution Crosslinking fix.
The described preparation method for drying bioprosthesis valve, wherein, use concentration molten for 0.1%~5% glutaraldehyde The bioprosthesis valve crosslinking that liquid is carried out 2~5 days at normal temperatures is fixed.
A kind of to dry bioprosthesis valve, it uses the preparation method described in any of the above to be obtained.
Beneficial effect:Bioprosthesis valve is dried using prepared by preparation method of the present invention, with good physics and chemistry Performance and biocompatibility;Preparation method of the present invention improves the service life of valve, make valve in the state of drying still Flexible nature can be kept, so as to reduce production, the cost of transportation of valve, the use flow of valve is simplified.
Brief description of the drawings
Fig. 1 is the reaction equation schematic diagram of aldehyde radical and carboxyl and hydroxyl in polymer in valve of the present invention.
Specific embodiment
Present invention offer is a kind of to dry bioprosthesis valve and preparation method thereof, to make the purpose of the present invention, technical scheme And effect is clearer, clear and definite, the present invention is described in more detail below.It should be appreciated that specific implementation described herein Example is only used to explain the present invention, is not intended to limit the present invention.
The invention by the bioprosthesis valve (abbreviation valve) after crosslinked fixation, by the polymerization of hydroxyl The treatment of thing solution, contained chemical functional group chemically reacts with group in valve in solution, while polymer is played to valve Submissiveization modifying function, is then processed through low temperature drying again, so that valve has good physicochemical property and biocompatibility, Improve the service life of valve.
The preparation method for drying bioprosthesis valve of present pre-ferred embodiments, including step:After crosslinked fixation Bioprosthesis valve immersion hydroxyl polymer solution in, immersion the scheduled time after take out at 5~45 DEG C dry, obtain Dry bioprosthesis valve.
In the present embodiment, the drying of valve is 5~45 DEG C of low temperature drying.The present invention is by by the polymer of hydroxyl Bioprosthesis valve after mixed solution treatment takes out, and is dried under low-temperature condition, makes the artificial bio-membrane after being completely dried Valve, remains able to ensure good pliability and mechanical property.
It should be noted that bioprosthesis valve of the present invention includes but is not limited to pig pericardium heart valve, bovine pericardium valve Deng animal pericardium heart valve.
, it is necessary to be first crosslinked bioprosthesis valve before in the polymer solution of immersion hydroxyl, to be handed over Bioprosthesis valve after connection is fixed.In the present embodiment, the crosslinking for carrying out bioprosthesis valve using glutaraldehyde solution is fixed.
Preferably, the artificial bio-prosthetic valve for using concentration to be carried out at normal temperatures for 0.1%~5% glutaraldehyde solution 2~5 days Film crosslinking is fixed.Glutaraldehyde cross-linking is carried out to biovalve to fix, can eliminate the bioactivity of biovalve, make its power first Learn performance and endurance quality reaches requirement.
During specific implementation, can at normal temperatures be protected in the glutaraldehyde solution of bioprosthesis valve immersion 0.1%~5% Hold 2~5 days, and ensure the smooth expansion of valve simultaneously.
Generally, preparation method of the present invention includes:1. the crosslinking of biovalve;2. biovalve chemical treatment and Submissiveization treatment;3. low temperature drying.Wherein, biovalve chemical treatment and submissiveization are processed as committed step of the invention, its To mainly be soaked in the polymer solution of the bioprosthesis valve immersion hydroxyl after crosslinked fixation, made hydroxyl Polymer chemically reacts with bioprosthesis valve.
After the present invention is using valve crosslinking, it is chemically treated through hydroxyl polymer-containing, then is dehydrated through low temperature drying, drying is obtained Bioprosthesis valve.The polymer solution of hydroxyl is combined by chemical covalent bonds with valve surface, valve is also possessed very Good pliability, and excellent pliability can be in dry conditions remained in that, realize the kept dry of valve.It is simultaneously poly- The chemical functional group of polymer solution is chemically reacted with the aldehyde radical or carboxyl of residual in biovalve, is not only closed these and is dissociated Chemical group, reduces the adhesion of bioprosthetic valves and calcium ion, and significantly reduces valve material thickness and possess fold from calming down Function, tissue deactivates, and reduces the immunogenicity of material, enhances host ECs and climbs the ability of covering, and reduces valve at a specified future date The incidence of week leakage, increased the service life of biovalve.
Further, in the present embodiment, the polymer solution of the hydroxyl is polyethylene glycol, polyvinyl alcohol, polyethers One or more mixed solution in glycol solution.The polymer solution of the hydroxyl is a kind of to the nontoxic liquid of human body Body, and be a kind of excellent toughener.
As shown in figure 1, aldehyde radical and carboxylic of the polymer of hydroxyl of the present invention by residual in terminal hydroxyl and valve Base is chemically reacted, and valve surface is covered one layer of polymeric.The molecular weight of polymer is larger, then single polymer molecule exists The scope of valve surface covering is also larger, therefore the polymer of the hydroxyl is easy to assign the Chemical Physics performance of itself Bioprosthesis valve.
The present invention uses the polymer of the hydroxyl with toughening effect, can be by chemical covalent bonds and valve surface knot Close, valve is also possessed good pliability, valve is remained in that excellent pliability in dry conditions, so that real The kept dry of existing valve.
Further, in the present embodiment, the concentration of the polymer solution of the hydroxyl is 10%~50%.Namely It is, during the bioprosthesis valve immersion concentration after crosslinked fixation is the polymer solution of 10%~50% hydroxyl by the present invention Soaked.
Further, in the present embodiment, the bioprosthesis valve after crosslinked fixation is immersed the polymer of hydroxyl Drying is further taken out after being soaked 1~7 day in solution, i.e., the described scheduled time is 1~7 day.
Further, in the present embodiment, the bioprosthesis valve after crosslinked fixation is immersed the polymer of hydroxyl When being soaked in solution, soaking temperature is 25~45 DEG C.
Further, in the present embodiment, the bioprosthesis valve after crosslinked fixation is immersed the polymer of hydroxyl It is 3.0~5.5 by adding hydrochloric acid control solution pH value when being soaked in solution.Polymer is deposited due to space steric effect, reaction Speed it is slow, the time is long the shortcomings of, therefore the present invention is 3.0~5.5 by adjusting the pH value of solution, so as to activate artificial bio-membrane Aldehyde radical and carboxyl in valve, strengthen the reactivity of aldehyde radical and carboxyl in hydroxyl and valve in the polymer of hydroxyl.
During specific implementation, can be by the polymer of the hydroxyl of the good biovalve immersion 10%~50% of glutaraldehyde cross-linking 1~7 day in solution, temperature is controlled for 25~45 DEG C, while being 3.0~5.5 by adding hydrochloric acid control solution pH value, and ensure The smooth expansion of valve.
Further, bioprosthesis valve is dried present invention also offers a kind of, it is to dry people using above-described The preparation method of work biovalve is obtained.
The present invention makes leaflet thinner by unique dry film process technology, more firmly, more durable, and biocompatibility is more preferable, Proterties is more stable.The reduction of leaflet thickness causes the appearance and size reduction by 80% after valve compression, and the dry film process technique Realize valve and can be filled in induction system in advance and dispatch from the factory, can use at any time, without preoperative installation, shorten operating time, reduce The mortality risk for waiting valve to be caused during being implanted into patient's art.Drying and other treatment tissue deactivates, and need not be positioned over containing In the storing liquid of glutaraldehyde preserve can preloaded system, thoroughly solve valve endurance issues, improve the biofacies of valve Capacitive, reduces the endocarditis probability of happening that immunogene risk causes, and enhances host ECs and climbs and covers function, reduces Perivalvular leakage probability of happening.
The present invention is elaborated with specific embodiment below:
Embodiment 1
Pig pericardium heart valve is soaked 2 days in the glutaraldehyde solution that concentration is 5%, is taken out and is rinsed, after obtaining crosslinking fixation Bioprosthesis valve;Then fixed bioprosthesis valve will be crosslinked at a temperature of 45 DEG C, pH value is that 5.5, concentration is 20% Polyethylene glycol, polyvinyl alcohol solution in immersion take out after 7 days, be finally completely dried at 20 DEG C, obtain drying artificial Biovalve.
Find after testing, it is manufactured in the present embodiment to dry bioprosthesis valve, with excellent pliability, after valve compression Appearance and size reduction by 80%, and biocompatibility is good, proterties stabilization.
Embodiment 2
Pig pericardium heart valve is soaked 3 days in the glutaraldehyde solution that concentration is 4%, is taken out and is rinsed, after obtaining crosslinking fixation Bioprosthesis valve;Then fixed bioprosthesis valve will be crosslinked at a temperature of 40 DEG C, pH value is that 4.5, concentration is 30% Polyethylene glycol, polyvinyl alcohol solution in immersion take out after 5 days, be finally completely dried at 25 DEG C, obtain drying artificial Biovalve.
Find after testing, it is manufactured in the present embodiment to dry bioprosthesis valve, with excellent pliability, after valve compression Appearance and size reduction by 80%, and biocompatibility is good, proterties stabilization.
Embodiment 3
Pig pericardium heart valve is soaked 4 days in the glutaraldehyde solution that concentration is 3%, is taken out and is rinsed, after obtaining crosslinking fixation Bioprosthesis valve;Then fixed bioprosthesis valve will be crosslinked at a temperature of 35 DEG C, pH value is that 4.0, concentration is 40% Polyglycol solution in immersion 3 days after take out, be finally completely dried at 30 DEG C, obtain drying bioprosthesis valve.
Find after testing, it is manufactured in the present embodiment to dry bioprosthesis valve, with excellent pliability, after valve compression Appearance and size reduction by 80%, and biocompatibility is good, proterties stabilization.
Embodiment 4
Pig pericardium heart valve is soaked 5 days in the glutaraldehyde solution that concentration is 1%, is taken out and is rinsed, after obtaining crosslinking fixation Bioprosthesis valve;Then fixed bioprosthesis valve will be crosslinked at a temperature of 25 DEG C, pH value is that 3.0, concentration is 50% Polyglycol solution in immersion 1 day after take out, be finally completely dried at 45 DEG C, obtain drying bioprosthesis valve.
Find after testing, it is manufactured in the present embodiment to dry bioprosthesis valve, with excellent pliability, after valve compression Appearance and size reduction by 80%, and biocompatibility is good, proterties stabilization.
Embodiment 5
Pig pericardium heart valve is soaked 5 days in the glutaraldehyde solution that concentration is 0.1%, is taken out and is rinsed, obtained crosslinking and fix Bioprosthesis valve afterwards;Then fixed bioprosthesis valve will be crosslinked at a temperature of 25 DEG C, pH value is that 3.0, concentration is Taken out after being soaked 7 days in 10% polyether Glycols solution, be finally completely dried at 5 DEG C, obtain drying bioprosthesis valve.
Find after testing, it is manufactured in the present embodiment to dry bioprosthesis valve, with excellent pliability, after valve compression Appearance and size reduction by 80%, and biocompatibility is good, proterties stabilization.
In sum, bioprosthesis valve and preparation method thereof, the preparation method bag are dried the invention provides a kind of Include step:By in the polymer solution of the bioprosthesis valve immersion hydroxyl after crosslinked fixation, taken after the immersion scheduled time Go out and dried at 5~45 DEG C, obtain drying bioprosthesis valve.The drying prepared using preparation method of the present invention is manually given birth to Thing valve, with good physicochemical property and biocompatibility;Preparation method of the present invention improves the service life of valve, makes valve Film still can keep flexible nature in the state of drying, so as to reduce production, the cost of transportation of valve, simplify valve Use flow.
It should be appreciated that application of the invention is not limited to above-mentioned citing, and for those of ordinary skills, can To be improved according to the above description or converted, all these modifications and variations should all belong to the guarantor of appended claims of the present invention Shield scope.

Claims (9)

1. a kind of preparation method for drying bioprosthesis valve, it is characterised in that including step:It is artificial after by crosslinked fixation In the polymer solution of biovalve immersion hydroxyl, taken out after the immersion scheduled time and dried at 5~45 DEG C, obtain drying people Work biovalve.
2. the preparation method for drying bioprosthesis valve according to claim 1, it is characterised in that the hydroxyl it is poly- Polymer solution is one or more mixed solution in polyethylene glycol, polyvinyl alcohol, polyether Glycols solution.
3. the preparation method for drying bioprosthesis valve according to claim 1, it is characterised in that the hydroxyl it is poly- The concentration of polymer solution is 10%~50%.
4. the preparation method for drying bioprosthesis valve according to claim 1, it is characterised in that the scheduled time is 1~7 day.
5. the preparation method for drying bioprosthesis valve according to claim 1, it is characterised in that after crosslinked fixation Bioprosthesis valve immersion hydroxyl polymer solution in when soaking, soaking temperature is 25~45 DEG C.
6. the preparation method for drying bioprosthesis valve according to claim 1, it is characterised in that after crosslinked fixation Bioprosthesis valve immersion hydroxyl polymer solution in when soaking, by add hydrochloric acid control solution pH value for 3.0~ 5.5。
7. the preparation method for drying bioprosthesis valve according to claim 1, it is characterised in that use glutaraldehyde solution The crosslinking for carrying out bioprosthesis valve is fixed.
8. the preparation method for drying bioprosthesis valve according to claim 7, it is characterised in that use concentration for The bioprosthesis valve crosslinking that 0.1%~5% glutaraldehyde solution is carried out 2~5 days at normal temperatures is fixed.
9. it is a kind of to dry bioprosthesis valve, it is characterised in that using the preparation method system described in any one of claim 1~8 .
CN201710108807.0A 2017-02-27 2017-02-27 Dry artificial biological valve and preparation method thereof Active CN106913909B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710108807.0A CN106913909B (en) 2017-02-27 2017-02-27 Dry artificial biological valve and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710108807.0A CN106913909B (en) 2017-02-27 2017-02-27 Dry artificial biological valve and preparation method thereof

Publications (2)

Publication Number Publication Date
CN106913909A true CN106913909A (en) 2017-07-04
CN106913909B CN106913909B (en) 2020-09-01

Family

ID=59454253

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710108807.0A Active CN106913909B (en) 2017-02-27 2017-02-27 Dry artificial biological valve and preparation method thereof

Country Status (1)

Country Link
CN (1) CN106913909B (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109260517A (en) * 2018-09-19 2019-01-25 杭州启明医疗器械有限公司 One kind can pre-install dry biological cardiac valves and preparation method thereof
CN109820625A (en) * 2018-09-30 2019-05-31 四川大学 A kind of artificial bio-prosthetic valve membrane processing method of crosslinking
CN110507856A (en) * 2019-09-29 2019-11-29 四川大学 A kind of full prepackage is dry to intervene aorta petal membrane material and preparation method thereof
WO2020057414A1 (en) * 2018-09-19 2020-03-26 杭州启明医疗器械股份有限公司 Dry biological heart valve capable of rapidly absorbing water and flattening, and preparation method therefor
CN111494716A (en) * 2020-04-15 2020-08-07 青岛市妇女儿童医院(青岛市妇幼保健院、青岛市残疾儿童医疗康复中心、青岛市新生儿疾病筛查中心) Heart surgery autologous pericardium patch processor and rapid anti-calcification treatment method
WO2021254347A1 (en) * 2020-06-15 2021-12-23 杭州启明医疗器械股份有限公司 Valve material having long-acting antithrombosis property and preparation method therefor
EP3854424A4 (en) * 2018-09-19 2022-06-22 Venus MedTech (HangZhou), Inc. Preload biological heart valve capable of rapid rehydration and preparation method therefor
US11931253B2 (en) 2020-01-31 2024-03-19 4C Medical Technologies, Inc. Prosthetic heart valve delivery system: ball-slide attachment

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10653523B2 (en) 2017-01-19 2020-05-19 4C Medical Technologies, Inc. Systems, methods and devices for delivery systems, methods and devices for implanting prosthetic heart valves
US11857441B2 (en) 2018-09-04 2024-01-02 4C Medical Technologies, Inc. Stent loading device

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1306445A (en) * 1998-06-24 2001-08-01 蒙大拿基金会国际心脏学院 Process for making compliant dehydrated tissue for implantation
EP1248655A1 (en) * 2000-01-10 2002-10-16 St. Jude Medical, Inc. Biocompatible prosthetic tissue
CN101965205A (en) * 2007-12-21 2011-02-02 爱德华兹生命科学公司 Capping Bioprosthetic Tissue to Reduce Calcification
EP2497793B1 (en) * 2011-03-11 2016-07-27 Covidien LP Application of supercritical fluid technology for manufacturing soft tissue repair medical articles
CN106190949A (en) * 2015-05-08 2016-12-07 上海微创心通医疗科技有限公司 A kind of dry state animal derived collagenous tissue material and preparation method thereof and bioprosthesis

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1306445A (en) * 1998-06-24 2001-08-01 蒙大拿基金会国际心脏学院 Process for making compliant dehydrated tissue for implantation
EP1248655A1 (en) * 2000-01-10 2002-10-16 St. Jude Medical, Inc. Biocompatible prosthetic tissue
CN101965205A (en) * 2007-12-21 2011-02-02 爱德华兹生命科学公司 Capping Bioprosthetic Tissue to Reduce Calcification
EP2497793B1 (en) * 2011-03-11 2016-07-27 Covidien LP Application of supercritical fluid technology for manufacturing soft tissue repair medical articles
CN106190949A (en) * 2015-05-08 2016-12-07 上海微创心通医疗科技有限公司 A kind of dry state animal derived collagenous tissue material and preparation method thereof and bioprosthesis

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109260517A (en) * 2018-09-19 2019-01-25 杭州启明医疗器械有限公司 One kind can pre-install dry biological cardiac valves and preparation method thereof
WO2020057412A1 (en) * 2018-09-19 2020-03-26 杭州启明医疗器械股份有限公司 Pre-loadable dried biological heart valve and preparation method thereof
WO2020057414A1 (en) * 2018-09-19 2020-03-26 杭州启明医疗器械股份有限公司 Dry biological heart valve capable of rapidly absorbing water and flattening, and preparation method therefor
CN109260517B (en) * 2018-09-19 2020-10-30 杭州启明医疗器械股份有限公司 Prefillable dry biological heart valve and preparation method thereof
EP3854424A4 (en) * 2018-09-19 2022-06-22 Venus MedTech (HangZhou), Inc. Preload biological heart valve capable of rapid rehydration and preparation method therefor
CN109820625A (en) * 2018-09-30 2019-05-31 四川大学 A kind of artificial bio-prosthetic valve membrane processing method of crosslinking
CN110507856A (en) * 2019-09-29 2019-11-29 四川大学 A kind of full prepackage is dry to intervene aorta petal membrane material and preparation method thereof
US11931253B2 (en) 2020-01-31 2024-03-19 4C Medical Technologies, Inc. Prosthetic heart valve delivery system: ball-slide attachment
CN111494716A (en) * 2020-04-15 2020-08-07 青岛市妇女儿童医院(青岛市妇幼保健院、青岛市残疾儿童医疗康复中心、青岛市新生儿疾病筛查中心) Heart surgery autologous pericardium patch processor and rapid anti-calcification treatment method
WO2021254347A1 (en) * 2020-06-15 2021-12-23 杭州启明医疗器械股份有限公司 Valve material having long-acting antithrombosis property and preparation method therefor

Also Published As

Publication number Publication date
CN106913909B (en) 2020-09-01

Similar Documents

Publication Publication Date Title
CN106913909A (en) It is a kind of to dry bioprosthesis valve and preparation method thereof
CN107007887A (en) One kind crosslinking bioprosthesis valve and preparation method thereof
US11179238B2 (en) Methods of preparing and delivering a dry bioprosthetic valved conduit
EP2077718B1 (en) Biological tissue for surgical implantation
Meuris et al. Trileaflet aortic valve reconstruction with a decellularized pericardial patch in a sheep model
CN109833119B (en) Crosslinking method for improving biocompatibility of acellular matrix
CN106691631A (en) Integrated transcatheter interventional heart valve prosthesis system
CN109833517B (en) A kind of cross-linking treatment method improving biovalve elastin laminin stability
WO2020038293A1 (en) Method for treating biological valve using combination of enzymatic cross-linking and tea polyphenol
US11963869B2 (en) Methods of implanting a dry bioprosthetic valved conduit
CN111686304A (en) Small-size transcatheter artificial heart valve and preparation method thereof
WO2019092734A1 (en) Anti-calcification of a tissue

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
CB02 Change of applicant information
CB02 Change of applicant information

Address after: 310000 3 building 311, 88 Jiangling Road, Binjiang District, Hangzhou, Zhejiang

Applicant after: Hangzhou Qiming Medical Device Co., Ltd.

Address before: The South Ring Road of Binjiang District Hangzhou 310000 Zhejiang province No. 3738 friends tax building East Room 201

Applicant before: Hangzhou Qiming Medical Device Co., Ltd.

CB02 Change of applicant information
CB02 Change of applicant information

Address after: 310000 Room 311, 3/F, Building No. 88, Jiangling Road, Binjiang District, Hangzhou City, Zhejiang Province

Applicant after: Hangzhou Qiming Medical Devices Co., Ltd.

Address before: 310000 Room 311, 3/F, Building No. 88, Jiangling Road, Binjiang District, Hangzhou City, Zhejiang Province

Applicant before: Hangzhou Qiming Medical Device Co., Ltd.

GR01 Patent grant
GR01 Patent grant